A New Force-Activated Separation Device for the Prevention of Peripheral Intravenous Restarts.
Gregory A Panza, Lee Steere, Adam C Steinberg
PMID 35272303WHAT IT FOUND
Patients using a force-activated separation device had fewer combined IV complications than standard care, but no individual complication type showed a separate reduction.
Nurses may replace separated connectors, and therapy delays were lower with the device.
Key findings
01The primary outcome, total combined dislodgement, infiltration, and phlebitis, was significantly lower with the device than standard care (P < .01).
02The device group had 46% fewer total mechanical complications requiring restart than standard care, but individual complications were not significantly different.
03After controlling for time enrolled, standard care had greater estimated total delay in therapy than the device (P = .001).
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The trial was unblinded, and nurses recorded complications and event times. The significant primary result was a combined total; individual dislodgement, infiltration, and phlebitis were not significantly different. All catheters were placed by a dedicated vascular access team with a standard bundle, so results may not apply to units without that setup. The device manufacturer provided the device and an unrestricted grant. Cost savings are extrapolated from external estimates, not measured in the trial. Patients were adults expected to need IV therapy for at least 24 hours in selected inpatient units, so it may not apply to emergency or outpatient settings.
Declared interests
Lineus Medical provided the device and an unrestricted grant.
The easy way to misread this
Do not read the reported 46% reduction as evidence that each complication type was reduced or that the projected cost savings are proven. The significant finding was for combined total complications, and the financial impact was estimated from external data.